John A. Carter

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

Hartmut Schmidt, Márcia Waddington‐Cruz, Marc Botteman et al. · Muscle & Nerve · 2017 · 212 citations · Full text

Public Health, Health Sciences, Neurology +13

Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents

Xin Gao, Daniel Wendling, Marc Botteman et al. · Journal of Medical Economics · 2012 · 53 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +17

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A cost-effectiveness analysis

Sonya J. Snedecor, John A. Carter, Satyin Kaura et al. · Journal of Medical Economics · 2012 · 46 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies

Alan B. Ettinger, John A. Carter, Krithika Rajagopalan · Epilepsy & Behavior · 2018 · 40 citations

Medicine, Neurology, Pharmacotherapy +15

Corneal cross-linking versus conventional management for keratoconus: a lifetime economic model

Richard L. Lindstrom, John P. Berdahl, Eric D. Donnenfeld et al. · Journal of Medical Economics · 2020 · 36 citations · Full text

Medicine, Ophthalmology, Surgery +13